Jinjie Wang is the Director of Science and Healthcare at Canary Wharf Group, where he oversees the development of new sectors on the estate including life science and healthcare. With a versatile career at the company, Jinjie has previously held key roles across finance, development and investment functions. Jinjie holds an undergraduate degree from the University of Oxford, a master’s degree from the University of Cambridge, and an Executive MBA from the University of Chicago.

Emma is the Markets and Supply Chain Director within the New Hospital Programme and with her team, tracks, builds and nurtures a strong, confident, and competitive market of suppliers and partners for the New Hospital Programme, creating an environment for the supply chain to invest with confidence and allowing the market to collaborate and innovate.​ As a Chartered Civil Engineer and having over 20 years in engineering and infrastructure major programmes, Emma joined the New Hospital Programme from HS2, where she was Head of Change & Collaboration and prior to that was the Alliance Relationship Manager for East West Rail.​ In each of these roles Emma has focused on creating positive change within the sector achieved through a combination of; creating and implementing delivery models; effective strategic relationship, cultural and market development; a comprehensive understanding of the sector, organisation, system, and people; supported by the technical understanding of change, transformation, programme, and project management.​ Using this experience, Emma and her team are preparing to ensure that the market is ready to deliver the Programme’s new hospitals that will integrate innovative national standards for NHS England’s healthcare infrastructure, delivering improved value for money and enhanced social value.​

Dr Angela Kukula is CEO of MedCity, and Director of Life Sciences at London & Partners where she leads a team of professionals championing the development of the life sciences sector in London, promoting London as the premier global destination for life science, and supporting high growth life sciences companies to make their home in London and to thrive and grow. Angela has worked in the London Life Science ecosystem for over 12 years, most recently as Commercial Director at the Chelsea and Westminster hospital and prior to that as Director of Business and Innovation at the Institute of Cancer Research. She is an internationally recognised technology transfer specialist. She sits on the Board of Oxford University Innovation and is a past chair of Knowledge Exchange UK (then PraxisAuril), the professional body for technology transfer. She is passionate about supporting the next generation of life science leaders through her work as governor of two London secondary schools, one of which is a life sciences specialist academy. Angela completed her undergraduate Bachelor degree in Biochemistry at the University of Oxford, and her PhD in Molecular Immunology and Genetics at the Institute of Child Health, University of London. Angela also has an MBA specialising in Technology Management, and a LLM in Commercial Law.

I am a Consultant Paediatrician and also Clinical Director & Founder of The Children’s e-Hospital and The London PANS Clinic. I have a specialist interest in Paediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcus (PANDAS) and Paediatric Acute onset Neuropsychiatric Syndrome (PANS). I have treated more than 1400 PANDAS patients in the UK, one of the largest single cohort of patients in Europe. I spent the early part of my career as a Lecturer in Paediatrics & Child Health. In my early years after qualification I was part of a team that studied the use of Botulinum Toxin to help children with cerebral palsy walk. This led to the first NHS clinic for botulinum toxin therapy (for children with cerebral palsy) in the United Kingdom. For this piece of work, I was awarded the Michael Blacow Memorial Prize by the Royal College of Paediatrics and Child Health. Following this I was awarded a Medical Research Council Clinical Training Fellowship Award and spent 3 years in molecular research. I graduated from the Nye Bevan NHS Leadership Academy Executive Training Programme in 2016. It was around the same time that I realised that the NHS needed to develop new ways of working if it was to survive.I set up The Children’s e-Hospital in 2015 and this has gone from strength to strength. We were the world’s first online child health service and our patient satisfaction rates are through the roof. We have been rated "Outstanding" by The CQC. Over the past 12 years I have developed The Children’s e-Hospital PANDAS service. I am a founder member of The UK PANDAS & PANS Physician’s Network and together with paediatric neurologists, paediatricians and immunologists from major centres around the UK (including the Evelina Children's Hospital, Alder Hey Children's Hospital and Birmingham Children's Hospital) we are working hard to raise awareness of PANDAS in the UK. I am a member of the Scientific & Medical Advisory group of The European Immunopsychiatric Association

Giulia Carravieri is the Head of international Business Development for ATI Project, in charge of entering new markets and consolidating the company presence in different sectors like healthcare, education, offices, living, data centre and sport. Before joining ATI Project to create and direct the international and private acquisition sector, she has acquired her experience in Business Development at UNStudio (Amsterdam), in Project Management at Studio Fuksas (Rome) and in Architecture at Renzo Piano Building Workshop (Genoa and Paris). She combines technical knowledge, having graduated in Architecture from Genoa University, and strategic approach to markets, thanks to an MBA she has earned at Robert Gordon University in UK. Having lived, worked and studied across Europe, Giulia currently speaks Italian, French and English.

Richard is the EMEA Subject Matter Expert, Life Sciences, and UK Head of Project Management, Life Sciences for JLL Project & Development Services (PDS) responsible for leading the national team of experts across a variety of service line disciplines to deliver lasting value from built assets to science and technology clients. Richard has over 20 years’ experience in a wide variety of sectors, specialising in science & technology, pharmaceutical & life sciences project, and programme delivery. Richard has successfully managed projects and programmes in secure and controlled environments in the pharmaceutical and life sciences sectors including high containment laboratories, vivariums, cleanrooms, GMP and research and development. His key client work and experience include central government bodies and departments, research institutes, global big pharmaceutical and biotechnology companies, and higher education universities. Richard is also a Committee Member of the Association for Project Management (APM) Programme Management Specific Interest Group (SIG).

George leads the EMEA real estate research strategy dedicated to the life sciences sector. With over 14 years' experience in the fields of urban development, corporate real estate and territorial strategy, George previously contributed (2019 to 2023) at JLL to delivering various tailor-made studies to guide strategic choices of real estate players. George also worked at the Bordeaux Métropole Urban Planning Agency and for 6 years at the Etablissement Public Foncier d'Ile-de-France.​ ​ Today, he coordinates and deploys JLL’s EMEA research dedicated to life sciences. This involves monitoring and collecting real estate data for the sector, producing thematic and market reports, and supporting teams in Life Sciences-related consulting assignments. ​